Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Global Hemostats Industry Research Report, Growth Trends and Competitive Analysis 2024-2030
Industry: Medical Devices & Consumables
Published Date: 2024-04-17
Pages: 182 Pages
Report ld: 2700762
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Hemostats Market Size(US$)
CAGR 2024-2030
5.9%
Market Size,2030
USD 4,120.4
Million
Market Snapshot
Market Size in 2024 (Value)
US$ 2,921.3 million
Market Forecast in 2030(Value)
US$ 4,120.4 million
CAGR
5.9%
Years Considered
2019-2030
Base Year
2024
Forecast Period
2024-2030
Source: Secondary research, interviews with experts, and QYResearch analysis
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
The global Hemostats market size was US$ 2745.5 million in 2023 and is forecast to a readjusted size of US$ 4120.4 million by 2030 with a CAGR of 5.9% during the forecast period 2024-2030.
Global Hemostats key players include Ethicon, Inc., Pfizer, Inc., Baxter International Inc., C. R. Bard, The Medicines Company, etc. Global top five manufacturers hold a share over 55%.
North America is the largest market, with a share about 35%, followed by China, and Europe, both have a share over 35 percent.
In terms of product, Thrombin-Based Hemostats is the largest segment, with a share over 40%. And in terms of application, the largest application is Hospital Treatment, followed by Prehospital Treatment, etc.
In terms of sales (consumption) side, this report focuses on the sales of Hemostats by regions (Countries), company, by type and by type. from 2019 to 2024 and forecast to 2030.
The global Hemostats market is thoroughly, accurately, and comprehensively assessed in the report with a large focus on market dynamics, market competition, regional growth, segmental analysis, and key growth strategies. Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of sales analysis, the authors of the report have provided reliable estimations and calculations for global revenue and sales by type segment of the global Hemostats market. These figures have been provided in terms of both revenue and sales for the period 2019-2030. Additionally, the report provides accurate figures for sales by region in terms of revenue as well as volume for the same period.
MARKET SEGMENTATION
By Company
- Ethicon
- Pfizer
- Baxter International Inc.
- C. R. Bard
- The Medicines Company
- Anika Therapeutics
- Advanced Medical Solutions
- Integra LifeSciences Corporation
- B Braun Melsungen AG
- Gelita Medical GmbH
- Equimedical
- Vascular Solutions
- Marine Polymer Technologies
- Z-Medica, LLC
- CryoLife
- BioCer Entwicklungs-GmbH.
- Biom'Up SAS
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Thrombin-Based Hemostats
- Oxidized Regenerated Cellulose Based Hemostats
- Combination Hemostats
- Gelatin Based Hemostats
- Collagen Based Hemostats
Segment by Application
- Prehospital Treatment
- Hospital Treatment
CHAPTER OUTLINE
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Hemostats in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 3: Detailed analysis of Hemostats manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 7: Europe by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 8: China by company, by type and by application, sales, and revenue for each segment.
Chapter 9: APAC (excluding China) by company, by type, by application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by company, by type, by application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Hemostats sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Report Overview
1.1 Hemostats Definition
1.2 Market by Type
1.2.1 Global Hemostats Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Thrombin-Based Hemostats
1.2.3 Oxidized Regenerated Cellulose Based Hemostats
1.2.4 Combination Hemostats
1.2.5 Gelatin Based Hemostats
1.2.6 Collagen Based Hemostats
1.3 Market Segment by Application
1.3.1 Global Hemostats Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Prehospital Treatment
1.3.3 Hospital Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Hemostats Sales
2.1 Global Hemostats Revenue Estimates and Forecasts 2019-2030
2.2 Global Hemostats Revenue by Region: 2019 VS 2023 VS 2030
2.3 Global Hemostats Revenue by Region
2.3.1 Global Hemostats Revenue by Region (2019-2024)
2.3.2 Global Hemostats Revenue by Region (2025-2030)
2.4 Global Hemostats Sales Quantity Estimates and Forecasts 2019-2030
2.5 Global Hemostats Sales Quantity by Region: 2019 VS 2023 VS 2030
2.6 Global Hemostats Sales Quantity by Region
2.6.1 Global Hemostats Sales Quantity by Region (2019-2024)
2.6.2 Global Hemostats Sales Quantity by Region (2025-2030)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Hemostats Sales Quantity by Manufacturers
3.1.1 Global Hemostats Sales Quantity by Manufacturers (2019-2024)
3.1.2 Global Hemostats Sales Quantity Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Companies by Hemostats Sales in 2023
3.2 Global Hemostats Revenue by Manufacturers
3.2.1 Global Hemostats Revenue by Manufacturers (2019-2024)
3.2.2 Global Hemostats Revenue Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Hemostats Revenue in 2023
3.3 Global Hemostats Sales Price by Manufacturers
3.4 Global Key Players of Hemostats, Industry Ranking, 2022 VS 2023
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hemostats, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hemostats, Product Offered and Application
3.8 Global Key Manufacturers of Hemostats, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Hemostats Sales Quantity by Type
4.1.1 Global Hemostats Historical Sales Quantity by Type (2019-2024)
4.1.2 Global Hemostats Forecasted Sales Quantity by Type (2025-2030)
4.1.3 Global Hemostats Sales Quantity Market Share by Type (2019-2030)
4.2 Global Hemostats Revenue by Type
4.2.1 Global Hemostats Historical Revenue by Type (2019-2024)
4.2.2 Global Hemostats Forecasted Revenue by Type (2025-2030)
4.2.3 Global Hemostats Revenue Market Share by Type (2019-2030)
4.3 Global Hemostats Price by Type
4.3.1 Global Hemostats Price by Type (2019-2024)
4.3.2 Global Hemostats Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Hemostats Sales Quantity by Application
5.1.1 Global Hemostats Historical Sales Quantity by Application (2019-2024)
5.1.2 Global Hemostats Forecasted Sales Quantity by Application (2025-2030)
5.1.3 Global Hemostats Sales Quantity Market Share by Application (2019-2030)
5.2 Global Hemostats Revenue by Application
5.2.1 Global Hemostats Historical Revenue by Application (2019-2024)
5.2.2 Global Hemostats Forecasted Revenue by Application (2025-2030)
5.2.3 Global Hemostats Revenue Market Share by Application (2019-2030)
5.3 Global Hemostats Price by Application
5.3.1 Global Hemostats Price by Application (2019-2024)
5.3.2 Global Hemostats Price Forecast by Application (2025-2030)
6 North America
6.1 North America Hemostats Sales by Company
6.1.1 North America Hemostats Revenue by Company (2019-2024)
6.1.2 North America Hemostats Sales Quantity by Company (2019-2024)
6.2 North America Hemostats Market Size by Type
6.2.1 North America Hemostats Sales Quantity by Type (2019-2030)
6.2.2 North America Hemostats Revenue by Type (2019-2030)
6.3 North America Hemostats Market Size by Application
6.3.1 North America Hemostats Sales Quantity by Application (2019-2030)
6.3.2 North America Hemostats Revenue by Application (2019-2030)
6.4 North America Hemostats Market Size by Country
6.4.1 North America Hemostats Revenue by Country: 2019 VS 2023 VS 2030
6.4.2 North America Hemostats Revenue by Country (2019-2030)
6.4.3 North America Hemostats Sales Quantity by Country (2019-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Hemostats Sales by Company
7.1.1 Europe Hemostats Sales Quantity by Company (2019-2024)
7.1.2 Europe Hemostats Revenue by Company (2019-2024)
7.2 Europe Hemostats Market Size by Type
7.2.1 Europe Hemostats Sales Quantity by Type (2019-2030)
7.2.2 Europe Hemostats Revenue by Type (2019-2030)
7.3 Europe Hemostats Market Size by Application
7.3.1 Europe Hemostats Sales Quantity by Application (2019-2030)
7.3.2 Europe Hemostats Revenue by Application (2019-2030)
7.4 Europe Hemostats Market Size by Country
7.4.1 Europe Hemostats Revenue by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Hemostats Revenue by Country (2019-2030)
7.4.3 Europe Hemostats Sales Quantity by Country (2019-2030)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Hemostats Sales by Company
8.1.1 China Hemostats Sales Quantity by Company (2019-2024)
8.1.2 China Hemostats Revenue by Company (2019-2024)
8.2 China Hemostats Market Size by Type
8.2.1 China Hemostats Sales Quantity by Type (2019-2030)
8.2.2 China Hemostats Revenue by Type (2019-2030)
8.3 China Hemostats Market Size by Application
8.3.1 China Hemostats Sales Quantity by Application (2019-2030)
8.3.2 China Hemostats Revenue by Application (2019-2030)
9 APAC (excluding China)
9.1 APAC Hemostats Sales by Company
9.1.1 APAC Hemostats Sales Quantity by Company (2019-2024)
9.1.2 APAC Hemostats Revenue by Company (2019-2024)
9.2 APAC Hemostats Market Size by Type
9.2.1 APAC Hemostats Sales Quantity by Type (2019-2030)
9.2.2 APAC Hemostats Revenue by Type (2019-2030)
9.3 APAC Hemostats Market Size by Application
9.3.1 APAC Hemostats Sales Quantity by Application (2019-2030)
9.3.2 APAC Hemostats Revenue by Application (2019-2030)
9.4 APAC Hemostats Market Size by Region
9.4.1 APAC Hemostats Revenue by Region: 2019 VS 2023 VS 2030
9.4.2 APAC Hemostats Revenue by Region (2019-2030)
9.4.3 APAC Hemostats Sales Quantity by Region (2019-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Hemostats Sales by Company
10.1.1 Middle East, Africa and Latin America Hemostats Sales Quantity by Company (2019-2024)
10.1.2 Middle East, Africa and Latin America Hemostats Revenue by Company (2019-2024)
10.2 Middle East, Africa and Latin America Hemostats Market Size by Type
10.2.1 Middle East, Africa and Latin America Hemostats Sales Quantity by Type (2019-2030)
10.2.2 Middle East, Africa and Latin America Hemostats Revenue by Type (2019-2030)
10.3 Middle East, Africa and Latin America Hemostats Market Size by Application
10.3.1 Middle East, Africa and Latin America Hemostats Sales Quantity by Application (2019-2030)
10.3.2 Middle East, Africa and Latin America Hemostats Revenue by Application (2019-2030)
10.4 Middle East, Africa and Latin America Hemostats Market Size by Country
10.4.1 Middle East, Africa and Latin America Hemostats Revenue by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa and Latin America Hemostats Revenue by Country (2019-2030)
10.4.3 Middle East, Africa and Latin America Hemostats Sales Quantity by Country (2019-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Ethicon
11.1.1 Ethicon Company Information
11.1.2 Ethicon Overview
11.1.3 Ethicon Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.1.4 Ethicon Hemostats Products and Services
11.1.5 Ethicon Hemostats SWOT Analysis
11.1.6 Ethicon Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Information
11.2.2 Pfizer Overview
11.2.3 Pfizer Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.2.4 Pfizer Hemostats Products and Services
11.2.5 Pfizer Hemostats SWOT Analysis
11.2.6 Pfizer Recent Developments
11.3 Baxter International Inc.
11.3.1 Baxter International Inc. Company Information
11.3.2 Baxter International Inc. Overview
11.3.3 Baxter International Inc. Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.3.4 Baxter International Inc. Hemostats Products and Services
11.3.5 Baxter International Inc. Hemostats SWOT Analysis
11.3.6 Baxter International Inc. Recent Developments
11.4 C. R. Bard
11.4.1 C. R. Bard Company Information
11.4.2 C. R. Bard Overview
11.4.3 C. R. Bard Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.4.4 C. R. Bard Hemostats Products and Services
11.4.5 C. R. Bard Hemostats SWOT Analysis
11.4.6 C. R. Bard Recent Developments
11.5 The Medicines Company
11.5.1 The Medicines Company Company Information
11.5.2 The Medicines Company Overview
11.5.3 The Medicines Company Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.5.4 The Medicines Company Hemostats Products and Services
11.5.5 The Medicines Company Hemostats SWOT Analysis
11.5.6 The Medicines Company Recent Developments
11.6 Anika Therapeutics
11.6.1 Anika Therapeutics Company Information
11.6.2 Anika Therapeutics Overview
11.6.3 Anika Therapeutics Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.6.4 Anika Therapeutics Hemostats Products and Services
11.6.5 Anika Therapeutics Hemostats SWOT Analysis
11.6.6 Anika Therapeutics Recent Developments
11.7 Advanced Medical Solutions
11.7.1 Advanced Medical Solutions Company Information
11.7.2 Advanced Medical Solutions Overview
11.7.3 Advanced Medical Solutions Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.7.4 Advanced Medical Solutions Hemostats Products and Services
11.7.5 Advanced Medical Solutions Hemostats SWOT Analysis
11.7.6 Advanced Medical Solutions Recent Developments
11.8 Integra LifeSciences Corporation
11.8.1 Integra LifeSciences Corporation Company Information
11.8.2 Integra LifeSciences Corporation Overview
11.8.3 Integra LifeSciences Corporation Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.8.4 Integra LifeSciences Corporation Hemostats Products and Services
11.8.5 Integra LifeSciences Corporation Hemostats SWOT Analysis
11.8.6 Integra LifeSciences Corporation Recent Developments
11.9 B Braun Melsungen AG
11.9.1 B Braun Melsungen AG Company Information
11.9.2 B Braun Melsungen AG Overview
11.9.3 B Braun Melsungen AG Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.9.4 B Braun Melsungen AG Hemostats Products and Services
11.9.5 B Braun Melsungen AG Hemostats SWOT Analysis
11.9.6 B Braun Melsungen AG Recent Developments
11.10 Gelita Medical GmbH
11.10.1 Gelita Medical GmbH Company Information
11.10.2 Gelita Medical GmbH Overview
11.10.3 Gelita Medical GmbH Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.10.4 Gelita Medical GmbH Hemostats Products and Services
11.10.5 Gelita Medical GmbH Hemostats SWOT Analysis
11.10.6 Gelita Medical GmbH Recent Developments
11.11 Equimedical
11.11.1 Equimedical Company Information
11.11.2 Equimedical Overview
11.11.3 Equimedical Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.11.4 Equimedical Hemostats Products and Services
11.11.5 Equimedical Recent Developments
11.12 Vascular Solutions
11.12.1 Vascular Solutions Company Information
11.12.2 Vascular Solutions Overview
11.12.3 Vascular Solutions Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.12.4 Vascular Solutions Hemostats Products and Services
11.12.5 Vascular Solutions Recent Developments
11.13 Marine Polymer Technologies
11.13.1 Marine Polymer Technologies Company Information
11.13.2 Marine Polymer Technologies Overview
11.13.3 Marine Polymer Technologies Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.13.4 Marine Polymer Technologies Hemostats Products and Services
11.13.5 Marine Polymer Technologies Recent Developments
11.14 Z-Medica, LLC
11.14.1 Z-Medica, LLC Company Information
11.14.2 Z-Medica, LLC Overview
11.14.3 Z-Medica, LLC Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.14.4 Z-Medica, LLC Hemostats Products and Services
11.14.5 Z-Medica, LLC Recent Developments
11.15 CryoLife
11.15.1 CryoLife Company Information
11.15.2 CryoLife Overview
11.15.3 CryoLife Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.15.4 CryoLife Hemostats Products and Services
11.15.5 CryoLife Recent Developments
11.16 BioCer Entwicklungs-GmbH.
11.16.1 BioCer Entwicklungs-GmbH. Company Information
11.16.2 BioCer Entwicklungs-GmbH. Overview
11.16.3 BioCer Entwicklungs-GmbH. Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.16.4 BioCer Entwicklungs-GmbH. Hemostats Products and Services
11.16.5 BioCer Entwicklungs-GmbH. Recent Developments
11.17 Biom'Up SAS
11.17.1 Biom'Up SAS Company Information
11.17.2 Biom'Up SAS Overview
11.17.3 Biom'Up SAS Hemostats Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2019-2024)
11.17.4 Biom'Up SAS Hemostats Products and Services
11.17.5 Biom'Up SAS Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Hemostats Value Chain Analysis
12.2 Hemostats Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hemostats Production Mode & Process
12.4 Hemostats Sales and Marketing
12.4.1 Hemostats Sales Channels
12.4.2 Hemostats Distributors
12.5 Hemostats Customers
13 Market Dynamics
13.1 Hemostats Industry Trends
13.2 Hemostats Market Drivers
13.3 Hemostats Market Challenges
13.4 Hemostats Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Hemostats Market Size Growth Rate (CAGR) by Type, 2019 VS 2023 VS 2030 (US$ Million)
Table 2. Major Manufacturers of Thrombin-Based Hemostats
Table 3. Major Manufacturers of Oxidized Regenerated Cellulose Based Hemostats
Table 4. Major Manufacturers of Combination Hemostats
Table 5. Major Manufacturers of Gelatin Based Hemostats
Table 6. Major Manufacturers of Collagen Based Hemostats
Table 7. Global Hemostats Market Size Growth Rate (CAGR) by Application, 2019 VS 2023 VS 2030 (US$ Million)
Table 8. Global Hemostats Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 9. Global Hemostats Revenue by Region (2019-2024) & (US$ Million)
Table 10. Global Hemostats Revenue Market Share by Region (2019-2024)
Table 11. Global Hemostats Revenue by Region (2025-2030) & (US$ Million)
Table 12. Global Hemostats Revenue Market Share by Region (2025-2030)
Table 13. Global Hemostats Sales Quantity by Region: 2019 VS 2023 VS 2030 (K Pcs)
Table 14. Global Hemostats Sales by Region (2019-2024) & (K Pcs)
Table 15. Global Hemostats Sales Market Share by Region (2019-2024)
Table 16. Global Hemostats Sales by Region (2025-2030) & (K Pcs)
Table 17. Global Hemostats Sales Market Share by Region (2025-2030)
Table 18. Global Hemostats Sales Quantity by Manufacturers (2019-2024) & (K Pcs)
Table 19. Global Hemostats Sales Quantity Share by Manufacturers (2019-2024)
Table 20. Global Hemostats Revenue by Manufacturers (2019-2024) & (US$ Million)
Table 21. Global Hemostats Revenue Share by Manufacturers (2019-2024)
Table 22. Global Hemostats Price by Manufacturers 2019-2024 (USD/Pcs)
Table 23. Global Key Players of Hemostats, Industry Ranking, 2022 VS 2023
Table 24. Global Hemostats Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 25. Global Hemostats by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hemostats as of 2023)
Table 26. Global Key Manufacturers of Hemostats, Manufacturing Base Distribution and Headquarters
Table 27. Global Key Manufacturers of Hemostats, Product Offered and Application
Table 28. Global Key Manufacturers of Hemostats, Date of Enter into This Industry
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Hemostats Sales Quantity by Type (2019-2024) & (K Pcs)
Table 31. Global Hemostats Sales Quantity by Type (2025-2030) & (K Pcs)
Table 32. Global Hemostats Sales Quantity Share by Type (2019-2024)
Table 33. Global Hemostats Sales Quantity Share by Type (2025-2030)
Table 34. Global Hemostats Revenue by Type (2019-2024) & (US$ Million)
Table 35. Global Hemostats Revenue by Type (2025-2030) & (US$ Million)
Table 36. Global Hemostats Revenue Share by Type (2019-2024)
Table 37. Global Hemostats Revenue Share by Type (2025-2030)
Table 38. Hemostats Price by Type (2019-2024) & (USD/Pcs)
Table 39. Global Hemostats Price Forecast by Type (2025-2030) & (USD/Pcs)
Table 40. Global Hemostats Sales Quantity by Application (2019-2024) & (K Pcs)
Table 41. Global Hemostats Sales Quantity by Application (2025-2030) & (K Pcs)
Table 42. Global Hemostats Sales Quantity Share by Application (2019-2024)
Table 43. Global Hemostats Sales Quantity Share by Application (2025-2030)
Table 44. Global Hemostats Revenue by Application (2019-2024) & (US$ Million)
Table 45. Global Hemostats Revenue by Application (2025-2030) & (US$ Million)
Table 46. Global Hemostats Revenue Share by Application (2019-2024)
Table 47. Global Hemostats Revenue Share by Application (2025-2030)
Table 48. Hemostats Price by Application (2019-2024) & (USD/Pcs)
Table 49. Global Hemostats Price Forecast by Application (2025-2030) & (USD/Pcs)
Table 50. North America Hemostats Revenue by Company (2019-2024) & (US$ Million)
Table 51. North America Hemostats Sales Quantity by Company (2019-2024) & (K Pcs)
Table 52. North America Hemostats Sales Quantity by Type (2019-2024) & (K Pcs)
Table 53. North America Hemostats Sales Quantity by Type (2025-2030) & (K Pcs)
Table 54. North America Hemostats Revenue by Type (2019-2024) & (US$ Million)
Table 55. North America Hemostats Revenue by Type (2025-2030) & (US$ Million)
Table 56. North America Hemostats Sales Quantity by Application (2019-2024) & (K Pcs)
Table 57. North America Hemostats Sales Quantity by Application (2025-2030) & (K Pcs)
Table 58. North America Hemostats Revenue by Application (2019-2024) & (US$ Million)
Table 59. North America Hemostats Revenue by Application (2025-2030) & (US$ Million)
Table 60. North America Hemostats Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 61. North America Hemostats Revenue by Country (2019-2024) & (US$ Million)
Table 62. North America Hemostats Revenue by Country (2025-2030) & (US$ Million)
Table 63. North America Hemostats Sales Quantity by Country (2019-2024) & (K Pcs)
Table 64. North America Hemostats Sales Quantity by Country (2025-2030) & (K Pcs)
Table 65. Europe Hemostats Sales Quantity by Company (2019-2024) & (K Pcs)
Table 66. Europe Hemostats Revenue by Company (2019-2024) & (US$ Million)
Table 67. Europe Hemostats Sales Quantity by Type (2019-2024) & (K Pcs)
Table 68. Europe Hemostats Sales Quantity by Type (2025-2030) & (K Pcs)
Table 69. Europe Hemostats Revenue by Type (2019-2024) & (US$ Million)
Table 70. Europe Hemostats Revenue by Type (2025-2030) & (US$ Million)
Table 71. Europe Hemostats Sales Quantity by Application (2019-2024) & (K Pcs)
Table 72. Europe Hemostats Sales Quantity by Application (2025-2030) & (K Pcs)
Table 73. Europe Hemostats Revenue by Application (2019-2024) & (US$ Million)
Table 74. Europe Hemostats Revenue by Application (2025-2030) & (US$ Million)
Table 75. Europe Hemostats Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 76. Europe Hemostats Revenue by Country (2019-2024) & (US$ Million)
Table 77. Europe Hemostats Revenue by Country (2025-2030) & (US$ Million)
Table 78. Europe Hemostats Sales Quantity by Country (2019-2024) & (K Pcs)
Table 79. Europe Hemostats Sales Quantity by Country (2025-2030) & (K Pcs)
Table 80. China Hemostats Sales Quantity by Company (2019-2024) & (K Pcs)
Table 81. China Hemostats Revenue by Company (2019-2024) & (US$ Million)
Table 82. China Hemostats Sales Quantity by Type (2019-2024) & (K Pcs)
Table 83. China Hemostats Sales Quantity by Type (2025-2030) & (K Pcs)
Table 84. China Hemostats Revenue by Type (2019-2024) & (US$ Million)
Table 85. China Hemostats Revenue by Type (2025-2030) & (US$ Million)
Table 86. China Hemostats Sales Quantity by Application (2019-2024) & (K Pcs)
Table 87. China Hemostats Sales Quantity by Application (2025-2030) & (K Pcs)
Table 88. China Hemostats Revenue by Application (2019-2024) & (US$ Million)
Table 89. China Hemostats Revenue by Application (2025-2030) & (US$ Million)
Table 90. APAC Hemostats Sales Quantity by Company (2019-2024) & (K Pcs)
Table 91. APAC Hemostats Revenue by Company (2019-2024) & (US$ Million)
Table 92. APAC Hemostats Sales Quantity by Type (2019-2024) & (K Pcs)
Table 93. APAC Hemostats Sales Quantity by Type (2025-2030) & (K Pcs)
Table 94. APAC Hemostats Revenue by Type (2019-2024) & (US$ Million)
Table 95. APAC Hemostats Revenue by Type (2025-2030) & (US$ Million)
Table 96. APAC Hemostats Sales Quantity by Application (2019-2024) & (K Pcs)
Table 97. APAC Hemostats Sales Quantity by Application (2025-2030) & (K Pcs)
Table 98. APAC Hemostats Revenue by Application (2019-2024) & (US$ Million)
Table 99. APAC Hemostats Revenue by Application (2025-2030) & (US$ Million)
Table 100. APAC Hemostats Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 101. APAC Hemostats Revenue by Region (2019-2024) & (US$ Million)
Table 102. APAC Hemostats Revenue by Region (2025-2030) & (US$ Million)
Table 103. APAC Hemostats Sales Quantity by Region (2019-2024) & (K Pcs)
Table 104. APAC Hemostats Sales Quantity by Region (2025-2030) & (K Pcs)
Table 105. Middle East, Africa and Latin America Hemostats Sales Quantity by Company (2019-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Hemostats Revenue by Company (2019-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Hemostats Sales Quantity by Type (2019-2024) & (K Pcs)
Table 108. Middle East, Africa and Latin America Hemostats Sales Quantity by Type (2025-2030) & (K Pcs)
Table 109. Middle East, Africa and Latin America Hemostats Revenue by Type (2019-2024) & (US$ Million)
Table 110. Middle East, Africa and Latin America Hemostats Revenue by Type (2025-2030) & (US$ Million)
Table 111. Middle East, Africa and Latin America Hemostats Sales Quantity by Application (2019-2024) & (K Pcs)
Table 112. Middle East, Africa and Latin America Hemostats Sales Quantity by Application (2025-2030) & (K Pcs)
Table 113. Middle East, Africa and Latin America Hemostats Revenue by Application (2019-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Hemostats Revenue by Application (2025-2030) & (US$ Million)
Table 115. Middle East, Africa and Latin America Hemostats Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 116. Middle East, Africa and Latin America Hemostats Revenue by Country (2019-2024) & (US$ Million)
Table 117. Middle East, Africa and Latin America Hemostats Revenue by Country (2025-2030) & (US$ Million)
Table 118. Middle East, Africa and Latin America Hemostats Sales Quantity by Country (2019-2024) & (K Pcs)
Table 119. Middle East, Africa and Latin America Hemostats Sales Quantity by Country (2025-2030) & (K Pcs)
Table 120. Ethicon Company Information
Table 121. Ethicon Description and Overview
Table 122. Ethicon Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 123. Ethicon Hemostats Product and Services
Table 124. Ethicon Hemostats SWOT Analysis
Table 125. Ethicon Recent Developments
Table 126. Pfizer Company Information
Table 127. Pfizer Description and Overview
Table 128. Pfizer Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 129. Pfizer Hemostats Product and Services
Table 130. Pfizer Hemostats SWOT Analysis
Table 131. Pfizer Recent Developments
Table 132. Baxter International Inc. Company Information
Table 133. Baxter International Inc. Description and Overview
Table 134. Baxter International Inc. Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 135. Baxter International Inc. Hemostats Product and Services
Table 136. Baxter International Inc. Hemostats SWOT Analysis
Table 137. Baxter International Inc. Recent Developments
Table 138. C. R. Bard Company Information
Table 139. C. R. Bard Description and Overview
Table 140. C. R. Bard Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 141. C. R. Bard Hemostats Product and Services
Table 142. C. R. Bard Hemostats SWOT Analysis
Table 143. C. R. Bard Recent Developments
Table 144. The Medicines Company Company Information
Table 145. The Medicines Company Description and Overview
Table 146. The Medicines Company Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 147. The Medicines Company Hemostats Product and Services
Table 148. The Medicines Company Hemostats SWOT Analysis
Table 149. The Medicines Company Recent Developments
Table 150. Anika Therapeutics Company Information
Table 151. Anika Therapeutics Description and Overview
Table 152. Anika Therapeutics Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 153. Anika Therapeutics Hemostats Product and Services
Table 154. Anika Therapeutics Hemostats SWOT Analysis
Table 155. Anika Therapeutics Recent Developments
Table 156. Advanced Medical Solutions Company Information
Table 157. Advanced Medical Solutions Description and Overview
Table 158. Advanced Medical Solutions Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 159. Advanced Medical Solutions Hemostats Product and Services
Table 160. Advanced Medical Solutions Hemostats SWOT Analysis
Table 161. Advanced Medical Solutions Recent Developments
Table 162. Integra LifeSciences Corporation Company Information
Table 163. Integra LifeSciences Corporation Description and Overview
Table 164. Integra LifeSciences Corporation Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 165. Integra LifeSciences Corporation Hemostats Product and Services
Table 166. Integra LifeSciences Corporation Hemostats SWOT Analysis
Table 167. Integra LifeSciences Corporation Recent Developments
Table 168. B Braun Melsungen AG Company Information
Table 169. B Braun Melsungen AG Description and Overview
Table 170. B Braun Melsungen AG Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 171. B Braun Melsungen AG Hemostats Product and Services
Table 172. B Braun Melsungen AG Hemostats SWOT Analysis
Table 173. B Braun Melsungen AG Recent Developments
Table 174. Gelita Medical GmbH Company Information
Table 175. Gelita Medical GmbH Description and Overview
Table 176. Gelita Medical GmbH Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 177. Gelita Medical GmbH Hemostats Product and Services
Table 178. Gelita Medical GmbH Hemostats SWOT Analysis
Table 179. Gelita Medical GmbH Recent Developments
Table 180. Equimedical Company Information
Table 181. Equimedical Description and Overview
Table 182. Equimedical Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 183. Equimedical Hemostats Product and Services
Table 184. Equimedical Recent Developments
Table 185. Vascular Solutions Company Information
Table 186. Vascular Solutions Description and Overview
Table 187. Vascular Solutions Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 188. Vascular Solutions Hemostats Product and Services
Table 189. Vascular Solutions Recent Developments
Table 190. Marine Polymer Technologies Company Information
Table 191. Marine Polymer Technologies Description and Overview
Table 192. Marine Polymer Technologies Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 193. Marine Polymer Technologies Hemostats Product and Services
Table 194. Marine Polymer Technologies Recent Developments
Table 195. Z-Medica, LLC Company Information
Table 196. Z-Medica, LLC Description and Overview
Table 197. Z-Medica, LLC Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 198. Z-Medica, LLC Hemostats Product and Services
Table 199. Z-Medica, LLC Recent Developments
Table 200. CryoLife Company Information
Table 201. CryoLife Description and Overview
Table 202. CryoLife Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 203. CryoLife Hemostats Product and Services
Table 204. CryoLife Recent Developments
Table 205. BioCer Entwicklungs-GmbH. Company Information
Table 206. BioCer Entwicklungs-GmbH. Description and Overview
Table 207. BioCer Entwicklungs-GmbH. Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 208. BioCer Entwicklungs-GmbH. Hemostats Product and Services
Table 209. BioCer Entwicklungs-GmbH. Recent Developments
Table 210. Biom'Up SAS Company Information
Table 211. Biom'Up SAS Description and Overview
Table 212. Biom'Up SAS Hemostats Sales Quantity (K Pcs), Revenue (US$ Million), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2019-2024)
Table 213. Biom'Up SAS Hemostats Product and Services
Table 214. Biom'Up SAS Recent Developments
Table 215. Key Raw Materials Lists
Table 216. Raw Materials Key Suppliers Lists
Table 217. Hemostats Distributors List
Table 218. Hemostats Customers List
Table 219. Hemostats Market Trends
Table 220. Hemostats Market Drivers
Table 221. Hemostats Market Challenges
Table 222. Hemostats Market Restraints
Table 223. Research Programs/Design for This Report
Table 224. Key Data Information from Secondary Sources
Table 225. Key Data Information from Primary Sources
List of Figures
Figure 1. Hemostats Product Picture
Figure 2. Global Hemostats Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Hemostats Market Share by Type in 2023 & 2030
Figure 4. Thrombin-Based Hemostats Product Picture
Figure 5. Oxidized Regenerated Cellulose Based Hemostats Product Picture
Figure 6. Combination Hemostats Product Picture
Figure 7. Gelatin Based Hemostats Product Picture
Figure 8. Collagen Based Hemostats Product Picture
Figure 9. Global Hemostats Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
Figure 10. Global Hemostats Market Share by Application in 2023 & 2030
Figure 11. Prehospital Treatment
Figure 12. Hospital Treatment
Figure 13. Hemostats Report Years Considered
Figure 14. Global Hemostats Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Hemostats Revenue 2019-2030 (US$ Million)
Figure 16. Global Hemostats Revenue Market Share by Region in Percentage: 2023 Versus 2030
Figure 17. Global Hemostats Sales Quantity 2019-2030 (K Pcs)
Figure 18. Global Hemostats Sales Quantity Market Share by Region (2019-2024)
Figure 19. Global Hemostats Sales Quantity Market Share by Region (2025-2030)
Figure 20. North America Hemostats Sales Quantity YoY (2019-2030) & (K Pcs)
Figure 21. North America Hemostats Revenue YoY (2019-2030) & (US$ Million)
Figure 22. Europe Hemostats Sales Quantity YoY (2019-2030) & (K Pcs)
Figure 23. Europe Hemostats Revenue YoY (2019-2030) & (US$ Million)
Figure 24. China Hemostats Sales Quantity YoY (2019-2030) & (K Pcs)
Figure 25. China Hemostats Revenue YoY (2019-2030) & (US$ Million)
Figure 26. APAC Hemostats Sales Quantity YoY (2019-2030) & (K Pcs)
Figure 27. APAC Hemostats Revenue YoY (2019-2030) & (US$ Million)
Figure 28. Middle East, Africa and Latin America Hemostats Sales Quantity YoY (2019-2030) & (K Pcs)
Figure 29. Middle East, Africa and Latin America Hemostats Revenue YoY (2019-2030) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Hemostats Sales Quantity in 2023
Figure 31. The Top 10 and Top 5 Players Market Share by Hemostats Revenue in 2023
Figure 32. Hemostats Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 33. Global Hemostats Sales Quantity Market Share by Type (2019-2030)
Figure 34. Global Hemostats Revenue Market Share by Type (2019-2030)
Figure 35. Global Hemostats Sales Quantity Market Share by Application (2019-2030)
Figure 36. Global Hemostats Revenue Market Share by Application (2019-2030)
Figure 37. North America Hemostats Revenue Market Share by Company in 2023
Figure 38. North America Hemostats Sales Quantity Market Share by Company in 2023
Figure 39. North America Hemostats Sales Quantity Market Share by Type (2019-2030)
Figure 40. North America Hemostats Revenue Market Share by Type (2019-2030)
Figure 41. North America Hemostats Sales Quantity Market Share by Application (2019-2030)
Figure 42. North America Hemostats Revenue Market Share by Application (2019-2030)
Figure 43. North America Hemostats Revenue Share by Country (2019-2030)
Figure 44. North America Hemostats Sales Quantity Share by Country (2019-2030)
Figure 45. U.S. Hemostats Revenue (2019-2030) & (US$ Million)
Figure 46. Canada Hemostats Revenue (2019-2030) & (US$ Million)
Figure 47. Europe Hemostats Sales Quantity Market Share by Company in 2023
Figure 48. Europe Hemostats Revenue Market Share by Company in 2023
Figure 49. Europe Hemostats Sales Quantity Market Share by Type (2019-2030)
Figure 50. Europe Hemostats Revenue Market Share by Type (2019-2030)
Figure 51. Europe Hemostats Sales Quantity Market Share by Application (2019-2030)
Figure 52. Europe Hemostats Revenue Market Share by Application (2019-2030)
Figure 53. Europe Hemostats Revenue Share by Country (2019-2030)
Figure 54. Europe Hemostats Sales Quantity Share by Country (2019-2030)
Figure 55. Germany Hemostats Revenue (2019-2030) & (US$ Million)
Figure 56. France Hemostats Revenue (2019-2030) & (US$ Million)
Figure 57. U.K. Hemostats Revenue (2019-2030) & (US$ Million)
Figure 58. Italy Hemostats Revenue (2019-2030) & (US$ Million)
Figure 59. Russia Hemostats Revenue (2019-2030) & (US$ Million)
Figure 60. China Hemostats Sales Quantity Market Share by Company in 2023
Figure 61. China Hemostats Revenue Market Share by Company in 2023
Figure 62. China Hemostats Sales Quantity Market Share by Type (2019-2030)
Figure 63. China Hemostats Revenue Market Share by Type (2019-2030)
Figure 64. China Hemostats Sales Quantity Market Share by Application (2019-2030)
Figure 65. China Hemostats Revenue Market Share by Application (2019-2030)
Figure 66. APAC Hemostats Sales Quantity Market Share by Company in 2023
Figure 67. APAC Hemostats Revenue Market Share by Company in 2023
Figure 68. APAC Hemostats Sales Quantity Market Share by Type (2019-2030)
Figure 69. APAC Hemostats Revenue Market Share by Type (2019-2030)
Figure 70. APAC Hemostats Sales Quantity Market Share by Application (2019-2030)
Figure 71. APAC Hemostats Revenue Market Share by Application (2019-2030)
Figure 72. APAC Hemostats Revenue Share by Region (2019-2030)
Figure 73. APAC Hemostats Sales Quantity Share by Region (2019-2030)
Figure 74. Japan Hemostats Revenue (2019-2030) & (US$ Million)
Figure 75. South Korea Hemostats Revenue (2019-2030) & (US$ Million)
Figure 76. China Taiwan Hemostats Revenue (2019-2030) & (US$ Million)
Figure 77. Southeast Asia Hemostats Revenue (2019-2030) & (US$ Million)
Figure 78. India Hemostats Revenue (2019-2030) & (US$ Million)
Figure 79. Middle East, Africa and Latin America Hemostats Sales Quantity Market Share by Company in 2023
Figure 80. Middle East, Africa and Latin America Hemostats Revenue Market Share by Company in 2023
Figure 81. Middle East, Africa and Latin America Hemostats Sales Quantity Market Share by Type (2019-2030)
Figure 82. Middle East, Africa and Latin America Hemostats Revenue Market Share by Type (2019-2030)
Figure 83. Middle East, Africa and Latin America Hemostats Sales Quantity Market Share by Application (2019-2030)
Figure 84. Middle East, Africa and Latin America Hemostats Revenue Market Share by Application (2019-2030)
Figure 85. Middle East, Africa and Latin America Hemostats Sales Quantity Share by Country (2019-2030)
Figure 86. Middle East, Africa and Latin America Hemostats Revenue Share by Country (2019-2030)
Figure 87. Brazil Hemostats Revenue (2019-2030) & (US$ Million)
Figure 88. Mexico Hemostats Revenue (2019-2030) & (US$ Million)
Figure 89. Turkey Hemostats Revenue (2019-2030) & (US$ Million)
Figure 90. Israel Hemostats Revenue (2019-2030) & (US$ Million)
Figure 91. GCC Countries Hemostats Revenue (2019-2030) & (US$ Million)
Figure 92. Hemostats Value Chain
Figure 93. Hemostats Production Process
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Distributors Profiles
Figure 96. Bottom-up and Top-down Approaches for This Report
Figure 97. Data Triangulation
Figure 98. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Hemostats market size from 2024 to 2030?
The annual compound growth rate of the global Hemostats market is 5.9% 2024 to 2030.
What was the global market size of Hemostats in 2024?
Which region is expected to have the highest market share?
What was the global market size of Hemostats in 2030?
Which companies rank high in the global Hemostats market?
Related Reports
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-08
Pages: 175
USD 4900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-03-08
Pages: 104
USD 4250.00
(Single User License)
Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 134
USD 2900.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-03-08
Pages: 143
USD 3950.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-09-11
Pages: 173
USD 4900.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-28
Pages: 162
USD 5900.00
(Single User License)
Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-03-19
Pages: 106
USD 4250.00
(Single User License)
Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-01-16
Pages: 150
USD 3950.00
(Single User License)
Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-01-16
Pages: 106
USD 2900.00
(Single User License)
Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published Date: 2024-04-16
Pages: 160
USD 5900.00
(Single User License)
Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Hemostats market is projected to grow from US$ 2239 million in 2025 to US$ 3316 million by 2032, at a CAGR of 5.9% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-08
Pages: 175
USD 4900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Hemostats market size was US$ 2239 million in 2025 and is forecast to reach a readjusted size of US$ 3316 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-03-08
Pages: 104
USD 4250.00 (Single User License)Global Hemostats Market Research Report 2026
The global Hemostats market was valued at US$ 2239 million in 2025 and is anticipated to reach US$ 3316 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 134
USD 2900.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Hemostats was estimated to be worth US$ 2239 million in 2025 and is projected to reach US$ 3316 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-03-08
Pages: 143
USD 3950.00 (Single User License)Global Hemostats Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Hemostats market is projected to grow from US$ 3076 million in 2024 to US$ 4570 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-09-11
Pages: 173
USD 4900.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
In 2024, the global market size of Hemostats was estimated to be worth US$ 3076 million and is forecast to reach approximately US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-28
Pages: 162
USD 5900.00 (Single User License)Global Hemostats Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Hemostats market size was US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-03-19
Pages: 106
USD 4250.00 (Single User License)Hemostats- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Hemostats was estimated to be worth US$ 3076 million in 2024 and is forecast to a readjusted size of US$ 4570 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-01-16
Pages: 150
USD 3950.00 (Single User License)Global Hemostats Market Research Report 2025
The global market for Hemostats was valued at US$ 3076 million in the year 2024 and is projected to reach a revised size of US$ 4570 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-01-16
Pages: 106
USD 2900.00 (Single User License)Global Hemostats Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2024-2030
Hemostats are agents used to compress or treat bleeding vessels in order to arrest hemorrhage. These products may reduce operating room time and decrease the number of blood transfusions required in surgical procedures. Hemostatic gents are available in various forms including pads, sponges, liquids, and powders.
Published: 2024-04-16
Pages: 160
USD 5900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 5600.00
USD 8400.00
USD 11200.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now